Characteristics of proliferative diabetic retinopathy patients with postoperative vitreous hemorrhage after small-gauge vitrectomy

Author:

Zhao Meng1,Chandra Aman2,Xu Jun1,Li Jipeng1

Affiliation:

1. Beijing Tongren Eye Center, Capital Medical University

2. Mid & South Essex NHS Foundation Trust (Southend University Hospital) Prittlewell Chase Essex SS00RY

Abstract

Abstract Background: The role of anticoagulation or antiplatelet on post vitrectomy vitreous hemorrhage (POVH) in patients with proliferative diabetic retinopathy (PDR) is rarely investigated in small-gauge vitrectomy era. We investigate the relationship between long-term use of those medications and post vitrectomy POVH in a group of PDR patients.Methods: A retrospective cohort study was carried out in a group of PDR patients who underwent small-gauge vitrectomy in our center. The baseline data on diabetes, diabetic complications, anticoagulation or antiplatelet medications, ocular findings, and vitrectomy details were collected. The occurrence of POVH was recorded during the first three-month follow-up. Factors related to POVH were analyzed using logistic analysis.Results: During a median follow-up of 16 weeks, 5% (11/220) patients had persistent vitreous hemorrhage. Among 75 patients on antiplatelet or anticoagulation therapy, 34 patients were on aspirin, 5 were on heparin, 1 was on dabigatran, 15 were on dual antiplatelet therapy, and 7 were on combined therapy. The occurrence of POVH was not different between patients whose previous therapy was adjusted and whose was continued (0/22, 11/53, p=0.06).Factors related to persistent POVH were the use of antiplatelet or anticoagulation agents (5.98, 1.75-20.45, p=0.004), the presence of myocardial revascularization (130.65, 3.53-4834.50, p=0.08), the presence of coronary artery disease (CAD) treated with medicine (56.52, 1.99–1604.06, p=0.018), and younger age (0.86, 0.77-0.96, p=0.012)..Conclusions: We identified long-term use of anticoagulation or antiplatelet medication, the presence of CAD, and younger age as three independent factors related to POVH. In PDR patients on long-term antiplatelet or anticoagulation medications, particular attention should be given to controlling intraoperative bleeding, and follow-up for POVH should be scheduled.

Publisher

Research Square Platform LLC

Reference45 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3